Works matching IS 27696448 AND DT 2024 AND VI 3 AND IP 3

Results: 10

PGE2‐EP2/EP4 axis: A new perspective on cancer immunotherapy.
Published in:
Medcomm: Oncology, 2024, v. 3, n. 3, p. 1, doi. 10.1002/mog2.90
By:
- Chen, Lin;
- Xu, Yu‐Xin;
- Zhou, Jian‐Liang
Publication type:
Article
Extensive infiltration of CD8+ T cells and M1 macrophages is beneficial for multiple cancer patients undergoing chemotherapy.
Published in:
Medcomm: Oncology, 2024, v. 3, n. 3, p. 1, doi. 10.1002/mog2.89
By:
- Bai, Yuquan;
- Xu, He;
- Guo, Minzhang;
- Xia, Liang;
- Deng, Senyi
Publication type:
Article
Deciphering transcriptional bursts and enhancer dynamics: Advancing cancer therapeutics through single‐cell global run‐on sequencing.
Published in:
Medcomm: Oncology, 2024, v. 3, n. 3, p. 1, doi. 10.1002/mog2.88
By:
- Pan, Xiangyu;
- Na, Feifei;
- Chen, Xuelan
Publication type:
Article
CoCl2‐induced glioma hypoxia environment enhances CD47‐SIRPα to promote tumor immune evasion.
Published in:
Medcomm: Oncology, 2024, v. 3, n. 3, p. 1, doi. 10.1002/mog2.87
By:
- Ding, Xiangfei;
- Hou, Jianbing;
- Hu, Xiaosong;
- Peng, Wen;
- Li, Yongsen;
- Zhao, Gaichao;
- Cui, Hongjuan;
- Wu, Zonghui;
- Liang, Ping
Publication type:
Article
The prognostic value of microRNA‐200 family expression in digestive system tumors: A meta‐analysis and validation.
Published in:
Medcomm: Oncology, 2024, v. 3, n. 3, p. 1, doi. 10.1002/mog2.86
By:
- Wu, Xiaoshuang;
- Heng, Jinghua;
- Li, Mengxiang;
- Deng, Danxia;
- Wu, Bingli;
- Wang, Muting;
- Li, Sanqiang;
- Gao, Shegan;
- Qi, Yijun;
- Li, Enmin
Publication type:
Article
Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges.
Published in:
Medcomm: Oncology, 2024, v. 3, n. 3, p. 1, doi. 10.1002/mog2.85
By:
- Xu, Jie;
- Tian, Yaomei;
- Hu, Die;
- Yan, Xi;
- Yang, Li
Publication type:
Article
Early prediction of neoadjuvant chemotherapy efficacy for mass breast cancer based on dynamic contrast‐enhanced magnetic resonance imaging radiomics.
Published in:
Medcomm: Oncology, 2024, v. 3, n. 3, p. 1, doi. 10.1002/mog2.84
By:
- Cao, Pei‐Wei;
- Deng, Xue‐Ying;
- Pan, Yue‐Peng;
- Nan, Shuai‐Ming;
- Yu, Chang
Publication type:
Article
Alanyl‐tRNA synthetase AARS1: A novel lactate sensor and lactyltransferase mediating p53 lactylation and tumorigenesis.
Published in:
Medcomm: Oncology, 2024, v. 3, n. 3, p. 1, doi. 10.1002/mog2.83
By:
- Yang, Qiqing;
- Li, Heyu;
- Zhang, Long
Publication type:
Article
Next‐generation sequencing identifies that protein tyrosine phosphatase receptor type D mutation is favorable to immunotherapy in human cancer.
Published in:
Medcomm: Oncology, 2024, v. 3, n. 3, p. 1, doi. 10.1002/mog2.80
By:
- Huang, Yongsheng;
- Liao, Jianwei;
- Gao, Ming;
- Fu, Sha;
- Liang, Faya;
- Jiang, Yuanling;
- Luo, Jiahuan;
- Huang, Jinghua;
- Tan, Ni;
- Wang, Danlan;
- Yin, Xinke;
- Ren, Shuwei;
- Lin, Peiliang;
- Chen, Renhui;
- Han, Ping;
- Huang, Xiaoming;
- Ouyang, Nengtai
Publication type:
Article
Issue Information.
Published in:
Medcomm: Oncology, 2024, v. 3, n. 3, p. 1, doi. 10.1002/mog2.36
Publication type:
Article

Works matching IS 27696448 AND DT 2024 AND VI 3 AND IP 3

PGE<sub>2</sub>‐EP<sub>2</sub>/EP<sub>4</sub> axis: A new perspective on cancer immunotherapy.

Extensive infiltration of CD8<sup>+</sup> T cells and M1 macrophages is beneficial for multiple cancer patients undergoing chemotherapy.

Deciphering transcriptional bursts and enhancer dynamics: Advancing cancer therapeutics through single‐cell global run‐on sequencing.

CoCl<sub>2</sub>‐induced glioma hypoxia environment enhances CD47‐SIRPα to promote tumor immune evasion.

The prognostic value of microRNA‐200 family expression in digestive system tumors: A meta‐analysis and validation.

Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges.

Early prediction of neoadjuvant chemotherapy efficacy for mass breast cancer based on dynamic contrast‐enhanced magnetic resonance imaging radiomics.

Alanyl‐tRNA synthetase AARS1: A novel lactate sensor and lactyltransferase mediating p53 lactylation and tumorigenesis.

Next‐generation sequencing identifies that protein tyrosine phosphatase receptor type D mutation is favorable to immunotherapy in human cancer.

Issue Information.